GSTP1 and in situ carcinoma: As in previous studies of PhIP-induced prostatic neoplasia in rodents [41], [53], we found that the GSTP1 protein, which is silenced via promoter methylation in ∼90% of human prostate cancers, was decreased in cribiform PIN/CIS lesions in the rat ventral prostate.